Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
29.2M
-
Shares change
-
-749K
-
Total reported value, excl. options
-
$702M
-
Value change
-
-$15.8M
-
Put/Call ratio
-
0
-
Number of buys
-
55
-
Number of sells
-
-26
-
Price
-
$24.06
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q3 2022
105 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q3 2022.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.2M shares
of 132M outstanding shares and own 22.1% of the company stock.
Largest 10 shareholders include FMR LLC (3.58M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.08M shares), Column Group LLC (2.68M shares), BlackRock Inc. (2.06M shares), PERCEPTIVE ADVISORS LLC (1.71M shares), Ponoi Management, LLC (1.6M shares), VANGUARD GROUP INC (1.28M shares), STATE STREET CORP (1.27M shares), ORBIMED ADVISORS LLC (1.25M shares), and T. Rowe Price Investment Management, Inc. (1.24M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.